Bimekizumab is recommended for treating severe plaque psoriasis in draft NICE guidance, which was developed using a new way to review appraisals.

Public Health England has published advice and guidance for healthcare practitioners on the health needs of migrant patients.

Some people who have cholangiocarcinoma are now set to benefit from life-extending treatment pemigatinib after NICE published final draft guidance recommending it.

Following a review of the evidence, NICE has published draft updated guidelines with a new recommendation on the use of progesterone in threatened miscarriage.